Cantor Fitzgerald Maintains Overweight on AvePoint, Lowers Price Target to $15
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Cantor Fitzgerald analyst Thomas Blakey maintains AvePoint (NASDAQ:AVPT) with a Overweight and lowers the price target from $18 to $15.
Cantor Fitzgerald analyst Thomas Blakey maintains AvePoint (NASDAQ:AVPT) with a Overweight and lowers the price target from $18 to $15.